Morning Medical with Dr. Chow
A daily update covering the latest medical & health news from around the world using artificial intelligence. Doctor Chi-Ming Chow is a family physician, general internist, and cardiologist. He is also a Professor of Medicine at the University of Toronto.
Wegovy Side Effects, Acne Treatments, and Health Misinformation Insights
In this episode, Dr. Chi-Ming Chow delves into the latest medical developments, starting with hair loss as a side effect of semaglutide, particularly in Wegovy users, and examines recent research findings. He discusses the logistical and safety challenges faced by the FDA in implementing a return-to-office plan. The episode also covers the increasing off-label use of spironolactone for acne, focusing on safety and prescription trends. Dr. Chow explores the ongoing debate over measles boosters for adults, considering CDC recommendations. Laurel Bristow shares strategies to combat health misinformation. The episode concludes with a call to critical thinking, urging listeners to question and verify health information.
Key Points
- Recent reports indicate that women using semaglutide for weight loss may face a significantly higher risk of hair loss compared to those using bupropion-naltrexone.
- The transition back to in-person work at the FDA's main campus has led to significant logistical challenges, including overcrowded facilities and concerns about water safety.
- The rising off-label use of spironolactone for acne among young women underscores the need for further safety studies, given its established risks in other populations.
Chapters
| 0:00 | |
| 3:25 | |
| 5:42 | |
| 9:21 | |
| 12:43 | |
| 15:06 |
Transcript
Loading transcript...
- / -